In addition, RASSF1A promoter methylation was found in squamous cell carcinomas (10%), adenocarcinomas (20%), and adenosquamous carcinomas (45%), indicating that silenced RASSF1A may be involved in cervical adenocarcinoma progression [63, 64]. Here, RASSF1 is linked to adenocarcinoma.